The global endocrine function diagnostics market is anticipated to grow significantly over the forecast period. The endocrine system consists of a group of glands which produce and release hormones for the appropriate functioning of body functions. The most important function of these glands is to assist the body to change calories into energy to power cells and organs. These glands also play an integral role in determining the status of hormonal disorders in the human body such as diabetes, thyroid diseases, growth disorders and sexual dysfunction. Endocrine glands include adrenal glands, pineal gland, hypothalamus, pituitary glands, parathyroid, Islet cells in pancreas, testes, ovary, thymus and thyroid. A slight alteration in the functioning of any of these glands causes endocrine disorders. Endocrine disorders are classified into two major groups namely hormonal imbalance and disorders developed due to lesions. Some of the major endocrine disorders are diabetes, hyperthyroidism, hypothyroidism, polycystic ovary syndrome (PCOS) adrenal deficiency (e.g. Addison’s disease) and Cushing’s syndrome.
Diabetes testing is the largest market for the endocrine function diagnostics market. According to the International Diabetes Federation, the global prevalence of diabetes is expected to grow from 382 million in 2013 to 592 million in 2035. The growing prevalence of diabetes will serve the global endocrine function diagnostics market as a significant growth rendering driver. Moreover, the high prevalence of other diseases such as hyperthyroidism, hypothyroidism and polycystic ovary syndrome/PCOS (research results suggest that approximately 5% of the women of reproductive age are affected with this disease) will serve this market as a driver. Some of the other factors that will propel the growth of this market include the introduction of technologically advanced diagnostic technologies, growing market penetration of healthcare IT pertaining to system automation and the constantly improving regulatory and reimbursement frameworks across the globe.
North America holds majority of the market share of the overall endocrine function diagnostics market on account of the presence of high patient awareness levels coupled with relatively higher per capita healthcare expenditures. The Asia-Pacific market however will grow at the fastest rate during the forecast period owing to the presence of high unmet medical needs in emerging economies such as India and China.
This research study encompasses a competitive landscape of the endocrine function diagnostics market. Revenue analysis, product benchmarking and strategic developments of key market players such as Bio-Rad Laboratories, Abbott Laboratories, Roche Diagnostics, Siemens Healthcare, Beckman Coulter Inc., Dako, Sysmex, Thermo Fisher, Eiken and others are also provided in this report.
This report, by Grand View Research, takes a closer look at the endocrine function diagnostics industry, providing a holistic perspective on market dynamics, trends, supply and demand. The report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including cortisol, TSH, progesterone, free T3, free T4, T4, gastrin, LH, estradiol, TPO Ab, HCG, T3, T3 uptake, thyroglobulin Ab, prolactin, FSH, TBG, PTH/IO, PTH and testosterone. The report also provides the same level of information for key regional markets.
This research report analyzes various factors which has been driving and inhibiting the global endocrine function diagnostics market in the past. In addition, the report analyzes the impact of each driver and restraint on the market growth, which forms the base for market forecast. The report also showcases the opportunities available in the market which may act as future drivers for the market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor.